Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rare Diseases | 6 | 2024 | 631 | 1.790 |
Why?
|
Oligonucleotides, Antisense | 3 | 2023 | 461 | 1.400 |
Why?
|
RNA Splicing | 6 | 2023 | 905 | 1.330 |
Why?
|
Ataxia Telangiectasia | 3 | 2023 | 107 | 1.230 |
Why?
|
Autistic Disorder | 8 | 2021 | 1240 | 1.130 |
Why?
|
Genetic Diseases, Inborn | 3 | 2024 | 606 | 0.890 |
Why?
|
Tay-Sachs Disease | 1 | 2022 | 20 | 0.790 |
Why?
|
Genetic Testing | 14 | 2024 | 3591 | 0.770 |
Why?
|
Allelic Imbalance | 1 | 2019 | 77 | 0.640 |
Why?
|
Oligonucleotides | 1 | 2022 | 563 | 0.630 |
Why?
|
Genes, Recessive | 2 | 2019 | 625 | 0.620 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 134 | 0.620 |
Why?
|
Microcephaly | 5 | 2017 | 426 | 0.580 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 662 | 0.550 |
Why?
|
Neonatal Screening | 6 | 2023 | 619 | 0.510 |
Why?
|
Phenotype | 20 | 2024 | 16731 | 0.500 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 663 | 0.470 |
Why?
|
Information Dissemination | 1 | 2023 | 1141 | 0.460 |
Why?
|
Mutation | 23 | 2024 | 30266 | 0.450 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1038 | 0.440 |
Why?
|
Genetic Predisposition to Disease | 13 | 2021 | 18068 | 0.430 |
Why?
|
Mutation, Missense | 4 | 2019 | 2592 | 0.430 |
Why?
|
Genetic Association Studies | 8 | 2021 | 2748 | 0.430 |
Why?
|
Fragile X Syndrome | 1 | 2014 | 116 | 0.420 |
Why?
|
Exons | 5 | 2024 | 2395 | 0.400 |
Why?
|
Sequence Analysis, DNA | 8 | 2019 | 4785 | 0.400 |
Why?
|
Abnormalities, Multiple | 5 | 2024 | 1423 | 0.390 |
Why?
|
Nerve Tissue Proteins | 7 | 2016 | 4413 | 0.390 |
Why?
|
Centrioles | 3 | 2016 | 80 | 0.370 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2017 | 3612 | 0.370 |
Why?
|
Genome, Human | 7 | 2023 | 4456 | 0.330 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2010 | 350 | 0.330 |
Why?
|
Genetics, Medical | 2 | 2023 | 334 | 0.330 |
Why?
|
Genomics | 10 | 2024 | 5928 | 0.320 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8055 | 0.310 |
Why?
|
Intensive Care Units, Neonatal | 3 | 2024 | 862 | 0.300 |
Why?
|
Critical Illness | 2 | 2024 | 2754 | 0.290 |
Why?
|
Growth Cones | 3 | 2003 | 117 | 0.280 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2021 | 3730 | 0.260 |
Why?
|
Child Development Disorders, Pervasive | 4 | 2014 | 599 | 0.250 |
Why?
|
Pedigree | 9 | 2024 | 4545 | 0.250 |
Why?
|
Humans | 77 | 2024 | 768970 | 0.230 |
Why?
|
Gyrus Cinguli | 1 | 2010 | 1135 | 0.230 |
Why?
|
Osteochondrodysplasias | 2 | 2017 | 183 | 0.230 |
Why?
|
Intracranial Thrombosis | 1 | 2005 | 108 | 0.230 |
Why?
|
Introns | 2 | 2023 | 969 | 0.220 |
Why?
|
Cell Cycle Proteins | 4 | 2017 | 3450 | 0.220 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2024 | 147 | 0.220 |
Why?
|
5' Untranslated Regions | 1 | 2024 | 255 | 0.210 |
Why?
|
Infant, Newborn | 17 | 2024 | 26428 | 0.200 |
Why?
|
Ribosomal Proteins | 1 | 2024 | 370 | 0.200 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2016 | 344 | 0.200 |
Why?
|
Cerebral Revascularization | 1 | 2005 | 263 | 0.200 |
Why?
|
Databases, Genetic | 4 | 2017 | 1758 | 0.200 |
Why?
|
Nervous System | 2 | 2003 | 546 | 0.190 |
Why?
|
Pharmacogenetics | 2 | 2023 | 683 | 0.190 |
Why?
|
Cerebral Cortex | 3 | 2014 | 5831 | 0.190 |
Why?
|
Developmental Disabilities | 3 | 2024 | 1520 | 0.190 |
Why?
|
Genetic Variation | 5 | 2022 | 6611 | 0.190 |
Why?
|
Spasms, Infantile | 1 | 2024 | 301 | 0.180 |
Why?
|
Axons | 3 | 2004 | 1678 | 0.180 |
Why?
|
Cell Adhesion Molecules | 3 | 2004 | 1614 | 0.170 |
Why?
|
Cognition Disorders | 1 | 2014 | 3985 | 0.170 |
Why?
|
Receptors, Immunologic | 3 | 2004 | 1418 | 0.170 |
Why?
|
Thrombectomy | 1 | 2005 | 675 | 0.170 |
Why?
|
DNA Copy Number Variations | 5 | 2020 | 2055 | 0.170 |
Why?
|
Genome-Wide Association Study | 6 | 2017 | 12801 | 0.160 |
Why?
|
Brain | 7 | 2022 | 27453 | 0.160 |
Why?
|
Histone Acetyltransferases | 1 | 2021 | 335 | 0.160 |
Why?
|
Thiolester Hydrolases | 1 | 2020 | 91 | 0.160 |
Why?
|
Coloboma | 1 | 2019 | 60 | 0.160 |
Why?
|
Child | 20 | 2024 | 80960 | 0.160 |
Why?
|
Biotinidase | 1 | 2018 | 17 | 0.160 |
Why?
|
Nerve Growth Factors | 1 | 2001 | 564 | 0.160 |
Why?
|
Nervous System Malformations | 2 | 2019 | 243 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2017 | 3671 | 0.150 |
Why?
|
Genes, DCC | 1 | 2017 | 10 | 0.150 |
Why?
|
Receptors, Cell Surface | 4 | 2017 | 2820 | 0.150 |
Why?
|
Cell Communication | 2 | 2003 | 1660 | 0.150 |
Why?
|
Aconitate Hydratase | 1 | 2017 | 17 | 0.140 |
Why?
|
Drugs, Investigational | 1 | 2019 | 212 | 0.140 |
Why?
|
Congenital Abnormalities | 1 | 2022 | 704 | 0.140 |
Why?
|
Homozygote | 2 | 2020 | 1780 | 0.140 |
Why?
|
Infant | 12 | 2024 | 36556 | 0.140 |
Why?
|
Muscular Dystrophy, Facioscapulohumeral | 2 | 2016 | 49 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6982 | 0.140 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2020 | 284 | 0.140 |
Why?
|
Genetic Privacy | 1 | 2017 | 59 | 0.140 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2016 | 62 | 0.130 |
Why?
|
United States Food and Drug Administration | 1 | 2024 | 1672 | 0.130 |
Why?
|
Bioethical Issues | 1 | 2017 | 119 | 0.130 |
Why?
|
Health | 1 | 2019 | 398 | 0.130 |
Why?
|
Periventricular Nodular Heterotopia | 2 | 2014 | 57 | 0.130 |
Why?
|
Body Dysmorphic Disorders | 1 | 2019 | 243 | 0.120 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2016 | 239 | 0.120 |
Why?
|
Seizures | 3 | 2019 | 3000 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2015 | 185 | 0.120 |
Why?
|
Intracranial Aneurysm | 1 | 2005 | 1293 | 0.120 |
Why?
|
Male | 38 | 2024 | 365203 | 0.120 |
Why?
|
Ataxia | 1 | 2017 | 307 | 0.120 |
Why?
|
Female | 35 | 2024 | 397515 | 0.120 |
Why?
|
Cerebellum | 2 | 2019 | 1522 | 0.120 |
Why?
|
Infant Mortality | 1 | 2019 | 754 | 0.120 |
Why?
|
Chromosome Mapping | 4 | 2021 | 4625 | 0.110 |
Why?
|
GA-Binding Protein Transcription Factor | 1 | 2014 | 43 | 0.110 |
Why?
|
Cell Differentiation | 4 | 2016 | 11684 | 0.110 |
Why?
|
DNA Mutational Analysis | 4 | 2016 | 4124 | 0.110 |
Why?
|
Hypertrichosis | 1 | 2013 | 31 | 0.110 |
Why?
|
Retinitis Pigmentosa | 1 | 2017 | 395 | 0.110 |
Why?
|
KATP Channels | 1 | 2013 | 49 | 0.110 |
Why?
|
Myopathies, Nemaline | 1 | 2013 | 73 | 0.110 |
Why?
|
Disease | 1 | 2019 | 673 | 0.110 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2014 | 88 | 0.110 |
Why?
|
DNA Modification Methylases | 1 | 2014 | 210 | 0.110 |
Why?
|
Myofibrils | 1 | 2013 | 143 | 0.110 |
Why?
|
Caenorhabditis elegans Proteins | 4 | 2004 | 880 | 0.100 |
Why?
|
Chromosome Deletion | 2 | 2016 | 1390 | 0.100 |
Why?
|
Walker-Warburg Syndrome | 1 | 2012 | 15 | 0.100 |
Why?
|
Microfilament Proteins | 3 | 2019 | 1135 | 0.100 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2014 | 361 | 0.100 |
Why?
|
Gene Deletion | 1 | 2020 | 2674 | 0.100 |
Why?
|
Consanguinity | 2 | 2014 | 460 | 0.100 |
Why?
|
Family | 5 | 2018 | 3208 | 0.100 |
Why?
|
Ventricular Dysfunction | 1 | 2013 | 144 | 0.100 |
Why?
|
Muscle Development | 1 | 2014 | 258 | 0.100 |
Why?
|
Malformations of Cortical Development | 1 | 2014 | 176 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2017 | 16053 | 0.100 |
Why?
|
Nuclear Proteins | 2 | 2017 | 5804 | 0.100 |
Why?
|
Glycosyltransferases | 1 | 2012 | 114 | 0.100 |
Why?
|
Iodide Peroxidase | 1 | 2013 | 295 | 0.100 |
Why?
|
Drug Discovery | 1 | 2019 | 1068 | 0.090 |
Why?
|
Neuromuscular Diseases | 1 | 2014 | 261 | 0.090 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 450 | 0.090 |
Why?
|
Microtubule-Associated Proteins | 1 | 2016 | 1074 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 620 | 0.090 |
Why?
|
Child, Preschool | 10 | 2024 | 42683 | 0.090 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3836 | 0.090 |
Why?
|
Contractile Proteins | 1 | 2012 | 240 | 0.090 |
Why?
|
Cardiomegaly | 1 | 2013 | 591 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 344 | 0.090 |
Why?
|
Genetic Loci | 2 | 2021 | 2630 | 0.090 |
Why?
|
Cilia | 1 | 2014 | 498 | 0.090 |
Why?
|
Neural Pathways | 1 | 2001 | 3120 | 0.090 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2011 | 310 | 0.090 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 842 | 0.090 |
Why?
|
Neurons | 5 | 2023 | 9519 | 0.090 |
Why?
|
DNA Methylation | 1 | 2024 | 4432 | 0.090 |
Why?
|
Quantitative Trait, Heritable | 1 | 2013 | 540 | 0.090 |
Why?
|
DNA Replication | 1 | 2017 | 1428 | 0.090 |
Why?
|
Family Health | 2 | 2013 | 1255 | 0.090 |
Why?
|
Prospective Studies | 4 | 2023 | 54962 | 0.080 |
Why?
|
Pilot Projects | 1 | 2023 | 8748 | 0.080 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2013 | 391 | 0.080 |
Why?
|
Central Nervous System | 1 | 2017 | 1346 | 0.080 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 682 | 0.080 |
Why?
|
Williams Syndrome | 1 | 2011 | 195 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1010 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6214 | 0.080 |
Why?
|
Facies | 2 | 2021 | 224 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2013 | 724 | 0.070 |
Why?
|
Child Development | 1 | 2019 | 2336 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6805 | 0.070 |
Why?
|
Head | 1 | 2013 | 927 | 0.070 |
Why?
|
Protein Kinases | 1 | 2014 | 1611 | 0.070 |
Why?
|
Caenorhabditis elegans | 4 | 2004 | 1469 | 0.070 |
Why?
|
Computational Biology | 1 | 2019 | 3562 | 0.070 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1148 | 0.070 |
Why?
|
Doxorubicin | 1 | 2013 | 2234 | 0.070 |
Why?
|
Point Mutation | 1 | 2012 | 1596 | 0.070 |
Why?
|
Epilepsy | 2 | 2019 | 3326 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17629 | 0.070 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7148 | 0.070 |
Why?
|
Animals | 16 | 2019 | 169335 | 0.070 |
Why?
|
Amino Acid Sequence | 5 | 2019 | 13427 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2019 | 22296 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2003 | 9618 | 0.070 |
Why?
|
Genetic Counseling | 2 | 2021 | 634 | 0.060 |
Why?
|
Cohort Studies | 3 | 2021 | 41808 | 0.060 |
Why?
|
Skin | 1 | 2019 | 4506 | 0.060 |
Why?
|
United States | 6 | 2024 | 73186 | 0.060 |
Why?
|
Syndrome | 2 | 2024 | 3274 | 0.060 |
Why?
|
Synapses | 1 | 2014 | 1764 | 0.060 |
Why?
|
Brain Diseases | 1 | 2014 | 1558 | 0.060 |
Why?
|
Helminth Proteins | 2 | 2002 | 173 | 0.060 |
Why?
|
Comparative Genomic Hybridization | 2 | 2016 | 474 | 0.060 |
Why?
|
Genotype | 5 | 2021 | 13048 | 0.060 |
Why?
|
Adolescent | 9 | 2024 | 89244 | 0.060 |
Why?
|
Myopathies, Structural, Congenital | 2 | 2016 | 104 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 12806 | 0.060 |
Why?
|
Parents | 1 | 2018 | 3597 | 0.060 |
Why?
|
Brain Damage, Chronic | 1 | 2005 | 267 | 0.060 |
Why?
|
Electroencephalography | 1 | 2019 | 6317 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2680 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2014 | 7609 | 0.050 |
Why?
|
Software | 1 | 2017 | 4479 | 0.050 |
Why?
|
Case Management | 1 | 2005 | 277 | 0.050 |
Why?
|
Immunoprecipitation | 2 | 2016 | 874 | 0.050 |
Why?
|
Signal Transduction | 5 | 2016 | 23653 | 0.050 |
Why?
|
Chromatin | 1 | 2014 | 2981 | 0.050 |
Why?
|
Zebrafish | 4 | 2014 | 3037 | 0.050 |
Why?
|
RNA Splice Sites | 1 | 2023 | 213 | 0.050 |
Why?
|
Haploinsufficiency | 1 | 2024 | 334 | 0.050 |
Why?
|
Retroelements | 1 | 2023 | 163 | 0.050 |
Why?
|
Adult | 11 | 2024 | 223851 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2005 | 386 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2004 | 458 | 0.050 |
Why?
|
Blepharophimosis | 1 | 2021 | 21 | 0.050 |
Why?
|
Congenital Hypothyroidism | 1 | 2021 | 40 | 0.050 |
Why?
|
Proteins | 2 | 2013 | 6011 | 0.050 |
Why?
|
Glucose | 1 | 2013 | 4352 | 0.050 |
Why?
|
Animals, Genetically Modified | 2 | 2004 | 1564 | 0.050 |
Why?
|
Transcription Factors | 1 | 2021 | 12174 | 0.050 |
Why?
|
DNA Repair | 1 | 2010 | 2054 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2016 | 19023 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2013 | 3840 | 0.050 |
Why?
|
Scrotum | 1 | 2021 | 118 | 0.050 |
Why?
|
Psychomotor Disorders | 1 | 2021 | 149 | 0.050 |
Why?
|
Psychotic Disorders | 1 | 2016 | 3278 | 0.040 |
Why?
|
Teaching | 1 | 2008 | 1171 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2024 | 1498 | 0.040 |
Why?
|
Neurology | 1 | 2008 | 787 | 0.040 |
Why?
|
Schizophrenia | 2 | 2016 | 6987 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2022 | 2460 | 0.040 |
Why?
|
Patella | 1 | 2021 | 317 | 0.040 |
Why?
|
Cerebral Angiography | 1 | 2005 | 1272 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2013 | 3982 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 199 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6901 | 0.040 |
Why?
|
Craniofacial Abnormalities | 1 | 2021 | 320 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 255 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 906 | 0.040 |
Why?
|
Protein Conformation | 2 | 2017 | 3956 | 0.040 |
Why?
|
Focus Groups | 1 | 2024 | 1462 | 0.040 |
Why?
|
Rats | 2 | 2013 | 23786 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 6 | 2017 | 36854 | 0.040 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2005 | 1039 | 0.030 |
Why?
|
Distal Myopathies | 1 | 2016 | 18 | 0.030 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2016 | 43 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2019 | 499 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 60131 | 0.030 |
Why?
|
Minority Groups | 1 | 2024 | 1216 | 0.030 |
Why?
|
Genomic Structural Variation | 1 | 2017 | 80 | 0.030 |
Why?
|
Dentate Gyrus | 1 | 1997 | 165 | 0.030 |
Why?
|
Genetic Research | 1 | 2017 | 173 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 2422 | 0.030 |
Why?
|
Models, Molecular | 2 | 2017 | 5404 | 0.030 |
Why?
|
Base Sequence | 2 | 2017 | 12430 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2017 | 393 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2005 | 1410 | 0.030 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2014 | 13 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18354 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1376 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6086 | 0.030 |
Why?
|
Aminoacylation | 1 | 2014 | 9 | 0.030 |
Why?
|
Lissencephaly | 1 | 2014 | 36 | 0.030 |
Why?
|
Dystroglycans | 1 | 2014 | 62 | 0.030 |
Why?
|
Cytokines | 2 | 2023 | 7453 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2017 | 1162 | 0.030 |
Why?
|
Joint Instability | 1 | 2021 | 803 | 0.030 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 54 | 0.030 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2016 | 271 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 168 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2024 | 2986 | 0.030 |
Why?
|
Protein Binding | 2 | 2017 | 9344 | 0.030 |
Why?
|
Mental Disorders | 1 | 2013 | 6876 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2063 | 0.030 |
Why?
|
Cell Movement | 3 | 2004 | 5216 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2013 | 186 | 0.030 |
Why?
|
Genomic Instability | 1 | 2017 | 715 | 0.030 |
Why?
|
Glucose Clamp Technique | 1 | 2013 | 263 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 1 | 2014 | 463 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8559 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2884 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2013 | 208 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 203 | 0.030 |
Why?
|
Clathrin Heavy Chains | 1 | 2012 | 27 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2012 | 93 | 0.020 |
Why?
|
Informed Consent | 1 | 2018 | 1010 | 0.020 |
Why?
|
Heterozygote | 1 | 2019 | 2798 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2017 | 2342 | 0.020 |
Why?
|
Thrombopoietin | 1 | 2014 | 226 | 0.020 |
Why?
|
Triiodothyronine | 1 | 2013 | 492 | 0.020 |
Why?
|
Status Epilepticus | 1 | 1997 | 463 | 0.020 |
Why?
|
Age of Onset | 1 | 2019 | 3346 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2005 | 3008 | 0.020 |
Why?
|
Heart Defects, Congenital | 2 | 2021 | 4712 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2013 | 344 | 0.020 |
Why?
|
Aged | 2 | 2019 | 171786 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7603 | 0.020 |
Why?
|
Glycosylation | 1 | 2014 | 1101 | 0.020 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2011 | 122 | 0.020 |
Why?
|
Algorithms | 2 | 2017 | 14201 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2005 | 5369 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3383 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2015 | 968 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2012 | 1305 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1726 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2014 | 633 | 0.020 |
Why?
|
Gene Duplication | 1 | 2011 | 315 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2014 | 771 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2014 | 2179 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 598 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2013 | 737 | 0.020 |
Why?
|
Embryonic Development | 1 | 2014 | 724 | 0.020 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2011 | 263 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.020 |
Why?
|
Attitude to Health | 1 | 2018 | 2025 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2204 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2041 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1505 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2011 | 321 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2012 | 507 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5033 | 0.020 |
Why?
|
Binding Sites | 1 | 2017 | 6023 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 1836 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 755 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 1676 | 0.020 |
Why?
|
Mice | 4 | 2017 | 82072 | 0.020 |
Why?
|
Intelligence | 1 | 2013 | 927 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2013 | 1328 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2012 | 718 | 0.020 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2011 | 465 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
Internship and Residency | 1 | 2008 | 5956 | 0.020 |
Why?
|
Siblings | 1 | 2011 | 828 | 0.020 |
Why?
|
Cadherins | 1 | 2011 | 906 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2011 | 1083 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4265 | 0.020 |
Why?
|
Retina | 1 | 2017 | 2661 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1887 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7058 | 0.020 |
Why?
|
Drug Resistance | 1 | 2012 | 1599 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2003 | 3775 | 0.020 |
Why?
|
Education | 1 | 2008 | 533 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2014 | 2885 | 0.020 |
Why?
|
Health Care Costs | 1 | 2018 | 3270 | 0.020 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases | 1 | 2004 | 8 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2013 | 1904 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3433 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4179 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6291 | 0.010 |
Why?
|
Genes, Helminth | 1 | 2004 | 146 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7460 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2019 | 81903 | 0.010 |
Why?
|
Genes, Suppressor | 1 | 2003 | 47 | 0.010 |
Why?
|
Pregnancy | 2 | 2017 | 30265 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3810 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2012 | 1902 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2005 | 15889 | 0.010 |
Why?
|
Nerve Net | 1 | 2014 | 2359 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9684 | 0.010 |
Why?
|
rac GTP-Binding Proteins | 1 | 2003 | 163 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15879 | 0.010 |
Why?
|
Clinical Clerkship | 1 | 2008 | 569 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2012 | 1924 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14484 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2911 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15604 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2004 | 818 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 2001 | 455 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14752 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9565 | 0.010 |
Why?
|
Crohn Disease | 1 | 2013 | 2294 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10115 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15471 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 6002 | 0.010 |
Why?
|
Cues | 1 | 2004 | 878 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10486 | 0.010 |
Why?
|
Data Collection | 1 | 2008 | 3324 | 0.010 |
Why?
|
Education, Medical, Undergraduate | 1 | 2008 | 1085 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 839 | 0.010 |
Why?
|
Microtubules | 1 | 2004 | 1062 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4978 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15951 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2005 | 65480 | 0.010 |
Why?
|
DNA | 1 | 2012 | 7214 | 0.010 |
Why?
|
Parasympathomimetics | 1 | 1997 | 28 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2008 | 2784 | 0.010 |
Why?
|
Liver | 1 | 2013 | 7578 | 0.010 |
Why?
|
Mutagenesis | 1 | 2001 | 1229 | 0.010 |
Why?
|
Pilocarpine | 1 | 1997 | 64 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 1997 | 310 | 0.010 |
Why?
|
Muscles | 1 | 2001 | 1582 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24333 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2013 | 5131 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2067 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2013 | 4818 | 0.010 |
Why?
|
Middle Aged | 2 | 2012 | 223737 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9549 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3744 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74976 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1997 | 1742 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5801 | 0.010 |
Why?
|
Cell Division | 1 | 1997 | 4478 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 1997 | 1448 | 0.000 |
Why?
|
Models, Biological | 1 | 2004 | 9499 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 8144 | 0.000 |
Why?
|